Table 2.
Bleeding risk scores
| Bleeding risk scores |
Action |
Mehran et al |
CRUSADE |
|||
| variables | Values | Points | Values | Points | Values | Points |
| Sex | Male | 0 | Male | 0 | Male | 0 |
| Female | 4 | Female | 8 | Female | 8 | |
| Age (yr) | ≤ 40 | 0 | < 50 | 0 | ||
| 41-50 | 1 | 50-59 | 3 | |||
| 51-60 | 2 | 60-69 | 6 | |||
| 61-70 | 3 | 70-79 | 9 | |||
| 71-80 | 4 | ≥ 80 | 12 | |||
| 81-90 | 5 | |||||
| ≥ 91 | 6 | |||||
| Weight (kg) | ≤ 50 | 5 | ||||
| 51-70 | 4 | |||||
| 71-100 | 3 | |||||
| 101-120 | 2 | |||||
| 121-140 | 1 | |||||
| ≥ 141 | 0 | |||||
| Systolic blood pressure (mmHg) | ≤ 90 | 4 | ≤ 90 | 10 | ||
| 91-100 | 3 | 91-100 | 8 | |||
| 101-120 | 2 | 101-120 | 5 | |||
| 121-140 | 1 | 121-180 | 1 | |||
| 141-170 | 0 | 181-200 | 3 | |||
| 171-200 | 1 | ≥ 201 | 5 | |||
| ≥ 201 | 2 | |||||
| Heart rate (BPM) | ≤ 40 | 0 | ≤ 70 | 0 | ||
| 41-60 | 2 | 71-80 | 1 | |||
| 61-70 | 3 | 81-90 | 3 | |||
| 71-80 | 5 | 91-100 | 6 | |||
| 81-100 | 6 | 101-110 | 8 | |||
| 101-110 | 8 | 111-120 | 10 | |||
| 111-120 | 9 | ≥ 121 | 11 | |||
| 121-130 | 11 | |||||
| 131-150 | 12 | |||||
| ≥ 151 | 14 | |||||
| Signs of heart failure | None | 0 | No | 0 | ||
| Killip 2-3 | 3 | Yes | 7 | |||
| Cardiogenic shock | 15 | |||||
| Diabetes mellitus | No | 0 | No | 0 | ||
| Yes | 3 | Yes | 6 | |||
| Prior vascular disease | No | 0 | No | 0 | ||
| Yes | 3 | Yes | 6 | |||
| Home warfarin use | No | 0 | ||||
| Yes | 2 | |||||
| Antithrombotic medications | Heparin plus GPI | 0 | ||||
| Bivalirudin | -5 | |||||
| ECG changes | No ST changes | 0 | No ST elevation | 0 | ||
| ST depresión | 3 | ST elevation | 6 | |||
| ST transient elevation | 7 | |||||
| ST elevation | ||||||
| Troponine I | Normal | 0 | ||||
| Raised | 6 | |||||
| Serum creatinine (mg/dL) | < 0.80 | 0 | < 1.00 | 0 | ||
| 0.80-1.59 | 1 | 1.00-1.19 | 2 | |||
| 1.60-1.99 | 2 | 1.20-1.39 | 3 | |||
| 2.00-2.99 | 4 | 1.40-1.59 | 5 | |||
| 3.00-3.99 | 6 | 1.60-1.79 | 6 | |||
| 4.00-4.99 | 8 | 1.80-1.99 | 8 | |||
| 5.00-5.99 | 10 | ≥ 2.00 | 10 | |||
| ≥ 6.00 | 11 | |||||
| On dialysis | 11 | |||||
| Creatinine clearance (mL/min) | ≤ 15.0 | 39 | ||||
| 15.1-30.0 | 35 | |||||
| 30.1-60.0 | 28 | |||||
| 60.1-90.0 | 17 | |||||
| 90.1-120.0 | 7 | |||||
| > 120 | 0 | |||||
| Baseline hemoglobin (g/dL) | < 5.0 | 17 | ||||
| 5.0-7.9 | 15 | |||||
| 8.0-9.9 | 13 | |||||
| 10.0-10.9 | 12 | |||||
| 11.0-13.9 | 9 | |||||
| 14.0-15.9 | 6 | |||||
| ≥ 16.0 | 2 | |||||
| Baseline hematocrit (%) | < 31.0 | 9 | ||||
| 31.0-33.9 | 7 | |||||
| 34.0-36.9 | 3 | |||||
| 37.0-39.9 | 2 | |||||
| ≥ 40.0 | 0 | |||||
| Anemia | No | 0 | ||||
| Yes | 6 | |||||
| White blood cell count (giga/L) | < 10.0 | 0 | ||||
| 10.0-11.9 | 2 | |||||
| 12.0-13.9 | 3 | |||||
| 14.0-15.9 | 5 | |||||
| 16.0-17.9 | 6 | |||||
| 18.0-19.9 | 8 | |||||
| ≥ 20.0 | 10 | |||||
CRUSADE: The Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines; GPI: Glycoprotein IIb/IIIa inhibitors; ECG: Electrocardiography; BPM: Beats per minute.